B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SCAP

MOLECULAR TARGET

SREBF chaperone

UniProt: Q12770NCBI Gene: 229371 compounds

SCAP (SREBF chaperone) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SCAP

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Calcifediol0.691

About SCAP as a Drug Target

SCAP (SREBF chaperone) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented SCAP interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SCAP inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.